Carboprost

Carboprost is the (15S)-15 methyl analogue of naturally occurring prostaglandin F2 alpha (PGF2 alpha) with oxytocic activity. Mimicking endogenous PGF2 alpha, carboprost activates prostaglandin F receptor, a G-protein coupled receptor, on smooth muscle cells, thereby resulting in smooth muscle contractions. When administered intramuscularly on gravid subjects, this agent induces myometrium contractions, thereby initiating luteolysis and consequently parturition. Furthermore, carboprost’s action on vascular smooth muscle and gastrointestinal tract sphincters leads to raised blood pressure and induces vomiting or diarrhea, respectively. It is grouped under the following drug class(es): Oxytocics, Prostaglandins and Vasoconstrictors. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Carboprostum, Methyl-pgf2-alpha and Prostin 15M. Its PubChem CID is 5281075.

CAS No 35700-23-3
Molecular Formula C21H36O5
Molecular Weight 368.5 g/mol
Synonyms (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid

Frequently Asked Questions